Status:
COMPLETED
Smart SCALEs With Bioimpedance Analysis for Treatment Guidance in Decompensated Heart Failure
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Heart Failure; With Decompensation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this trial the measurement of whole body water will be compared to the standard method of measuring the body weight as treatment guidance in patients with decompensated heart failure. The Seca mBCA...
Detailed Description
Investigators will include 153 participants hospitalized in the University Hospital in Basel. Daily measurements of whole body water and body weight will be performed in each person until diuretic tre...
Eligibility Criteria
Inclusion
- able to give informed consent
- hospitalization because of decompensated heart failure treated with forced diuresis
- able to stand on the scale without help from others and able to hold handrails with both hands
Exclusion
- refusal to share personal data
- implantable electronic device (e.g. Pacemaker, etc.)
- condition that does not allow skin contact of soles of feet and scale or hands with handrail (leg prosthesis, wounds, bandage, etc.)
Key Trial Info
Start Date :
September 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2019
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT03288701
Start Date
September 4 2017
End Date
September 27 2019
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031